Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Ceribelli

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Expert Review of Clinical Immunology|September 13, 2019
Medical cannabis and cannabinoids in rheumatology: where are we now?Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 1, 2012
Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritisEnrico Vizzardi, Ilaria Cavazzana, Chiara Bazzani, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Clinical phenotypes and therapeutic outcomes in enteropathic arthritis: a multivariate analysis from a retrospective cohortNicoletta Luciano, Bernardo D'Onofrio, Enrico Brunetta, et al.
Journal of Clinical Immunology|October 27, 2012
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patientsWendy C Carcamo, Angela Ceribelli, S John Calise, et al.
Clinical and Experimental Rheumatology|August 26, 2014
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositisAngela Ceribelli, Micaela Fredi, Mara Taraborelli, et al.
Rheumatology Advances in Practice|September 12, 2024
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic diseaseBernardo D'Onofrio, Giulia Virelli, Elisa Pedrollo, et al.
Clinical Rheumatology|April 28, 2011
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodiesMalgorzata E Krzyszczak, Yi Li, Steven J Ross, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritisElena Generali, Maria De Santis, Natasa Isailovic, et al.
Arthritis and Rheumatism|March 23, 2011
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteinsMinoru Satoh, Jason Y F Chan, Steven J Ross, et al.
Frontiers in Immunology|December 19, 2024
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritisMaria De Santis, Antonio Tonutti, Natasa Isailovic, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Expert Review of Clinical Immunology|September 13, 2019
Medical cannabis and cannabinoids in rheumatology: where are we now?Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 1, 2012
Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritisEnrico Vizzardi, Ilaria Cavazzana, Chiara Bazzani, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Clinical phenotypes and therapeutic outcomes in enteropathic arthritis: a multivariate analysis from a retrospective cohortNicoletta Luciano, Bernardo D'Onofrio, Enrico Brunetta, et al.
Journal of Clinical Immunology|October 27, 2012
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patientsWendy C Carcamo, Angela Ceribelli, S John Calise, et al.
Clinical and Experimental Rheumatology|August 26, 2014
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositisAngela Ceribelli, Micaela Fredi, Mara Taraborelli, et al.
Rheumatology Advances in Practice|September 12, 2024
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic diseaseBernardo D'Onofrio, Giulia Virelli, Elisa Pedrollo, et al.
Clinical Rheumatology|April 28, 2011
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodiesMalgorzata E Krzyszczak, Yi Li, Steven J Ross, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritisElena Generali, Maria De Santis, Natasa Isailovic, et al.
Arthritis and Rheumatism|March 23, 2011
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteinsMinoru Satoh, Jason Y F Chan, Steven J Ross, et al.
Frontiers in Immunology|December 19, 2024
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritisMaria De Santis, Antonio Tonutti, Natasa Isailovic, et al.
Pageof 11